Table 1 Comparison of age, serum PSA levels and serum LL-37 levels in prostatitis, prostate cancer and control group
From: Role of serum cathelicidin in diagnosis of patient with prostatitis and prostate carcinoma
Prostatitis (n:30) | Prostate cancer (n:45) | Control (n:21) | p | |
|---|---|---|---|---|
Age median (min–max) years | 62 (31–83) | 70 (58–82) | 64 (36–80) | 0.001 |
PSA median (min–max/) ng/mL | 9.85 (3.9–405) | 23 (4–1200) | 1.23 (0.1–3.5) | 0.02 |
LL-37 median (min–max) ng/mL | 2.74 (1.24–7) | 3.73 (1.32–26.65) | 2.16 (0.8–5.04) | 0.005 |